Table 2.
Laboratory findings of patients populations with VS and VNS groups (Mean ± SD) or Md (IQR) or (n, %)
| All (n = 231) | VNS group (n = 186) | VS group (n = 45) | P | |
|---|---|---|---|---|
| White blood cell count/(L−1，×109) | 6.08 ± 1.94 | 6.05 ± 1.76 | 6.20 ± 2.59 | 0.716 |
| Neutrophil percentage/(%) | 72.30 (61.70，81.20) | 71.20 (60.08, 79.03) | 78.70 (69.50, 87.55) | ˂0.001 |
| Lymphocyte percentage/(%) | 18.20 (11.70，27.40) | 19.80 (12.20, 28.73) | 13.70 (8.55, 20.65) | 0.003 |
| Monocyte percentage/(%) | 7.10 (4.80，9.20) | 7.40 (5.50, 9.25) | 4.70 (2.95, 7.65) | 0.001 |
| Red blood cell count/(L−1, ×1012) | 4.14 (3.73，4.50) | 4.15 (3.76, 4.53) | 4.13 (3.57, 4.42) | 0.291 |
| Hemoglobin/(g·L−1) | 125.66 ± 17.90 | 126.27 ± 17.05 | 123.13 ± 21.08 | 0.292 |
| Platelet count/(L−1, ×109) | 208.00 (161.00，255.00) | 216.00 (167.75,263.25) | 143.00 (96.00,201.50) | ˂0.001 |
| Alanine aminotransferase/(U·L−1) | 22.00 (13.38，36.00) | 22.00 (13.88, 36.00) | 21.50 (12.25, 40.65) | 0.704 |
| Aspartate aminotransferase/(U·L-1) | 24.00 (18.00, 35.00) | 23.00 (18.00, 32.50) | 34.00 (20.50, 49.00) | 0.005 |
| Total bilirubin/(μmol·L−1) | 10.17 (7.15，13.90) | 10.05 (6.78, 12.83) | 11.98 (8.18, 17.32) | 0.004 |
| Direct bilirubin/(μmol·L−1) | 4.35 (3.10，6.05) | 4.16 (3.00，5.66) | 5.67 (3.82, 8.81) | ˂0.001 |
| Albumin/(g·L−1) | 36.22 ± 5.02 | 36.67 ± 4.76 | 34.34 ± 5.67 | 0.005 |
| Blood glucose/(mmol·L−1) | 6.45 (5.45, 8.32) | 6.26 (5.22, 8.21) | 7.66 (6.18，8.61) | 0.011 |
| Blood urea nitrogen/(mmol·L−1) | 5.65 (4.12, 7.51) | 5.50 (4.12, 6.88) | 7.15 (4.68, 9.32) | 0.003 |
| Creatinine/(μmol·L−1) | 69.85 (55.90, 83.00) | 68.80 (55.15, 81.05) | 77.10 (57.18, 93.25) | 0.069 |
| Uric acid/ (μmol·L−1) | 265.96 ± 102.76 | 266.13 ± 100.60 | 265.32 ± 112.12 | 0.963 |
| Lactate dehydrogenase/(U·L−1) | 223.00 (181.00, 273.50) | 211.00 (175.25，265.50) | 259.00 (195.00, 399.00) | ＜0.001 |
| Creatine kinase/(U·L−1) | 68.50 (40.25, 117.50) | 65.00 (40.00, 98.00) | 91.00 (43.50, 245.50) | 0.020 |
| Creatine kinase-MB/(U·L−1) | 11.65 (8.53, 15.08) | 11.80 (8.48, 15.00) | 11.25 (8.68, 17.53) | 0.647 |
| Total cholesterol/(mmol·L−1) | 3.69 (3.16, 4.25) | 3.78 (3.25, 4.41) | 3.48 (2.89, 3.96) | 0.025 |
| Triglycerides/(mmol·L−1) | 1.11 (0.82, 1.38) | 1.08 (0.82, 1.39) | 1.16 (0.80, 1.37) | 0.528 |
| Homocysteine/(μmol·L−1) | 13.90 (10.00, 19.15) | 12.95 (9.93, 17.75) | 17.80 ( (10.48, 22.40) | 0.009 |
| Lactic acid/(mmol·L−1) | 1.50 (1.10, 2.10) | 1.50 (1.00, 2.00) | 1.60 (1.30, 2.40) | 0.011 |
| Cystatin C/(mg·L−1) | 1.14 (0.93, 1.45) | 1.10 (0.92, 1.39) | 1.29 (1.03, 1.54) | 0.021 |
| Myoglobin/(ng·ml−1) | 63.00 (44.00, 126.00) | 57.85 (43.00, 109.08) | 144.00 (61.00, 436.00) | ˂0.001 |
| Troponin I/(ng·ml−1) | 0.54 (0.40，0.67) | 0.53 (0.04, 0.65) | 0.57 (0.48, 0.80) | 0.011 |
| N-terminal pro-brain Natriuretic peptide/(pg·ml−1) | 268.50 (107.00, 980.25) | 219.50 (94.00, 646.50) | 879.00 (221.00, 1689.75) | 0.001 |
| C-reactive protein/(mg·L−1) | 30.40 (6.70, 81.80) | 20.95 (5.53, 74.78) | 64.80 (27.25, 116.00) | ˂0.001 |
| Erythrocyte sedimentation rate/(mm·h−1) | 42.50 (18.25, 70.00) | 36.00 (16.00, 65.00) | 64.00 (33.00, 80.00) | 0.042 |
| Procalcitonin/(ng·ml−1) | 0.06 (0.01, 0.16) | 0.04 (0.01, 0.11) | 0.17 (0.07, 0.28) | ˂0.001 |
| Ferritin/(ng·ml−1) | 367.20 (217.10, 717.10) | 305.60 (171.70, 631.20) | 760.30 (501.25, 928.43) | 0.002 |
| Prothrombin time/(s) | 12.10 (11.40, 13.00) | 12.20 (11.30, 12.90) | 12.10 (11.45, 13.48) | 0.685 |
| Prothrombin activity/(%) | 87.62 ± 12.60 | 88.22 ± 12.55 | 85.23 ± 12.65 | 0.159 |
| INR | 1.09 (1.03, 1.15) | 1.07 (1.02, 1.15) | 1.10 (1.04, 1.23) | 0.104 |
| APTT/(s) | 31.50 (29.18, 34.33) | 31.40 (28.90, 34.10) | 32.50 (30.60, 35.05) | 0.039 |
| Fibrinogen/(g·L-1) | 4.02 (3.35, 4.87) | 3.99 (3.34, 4.94) | 4.06 (3.59, 4.77) | 0.908 |
| Thrombin time/(s) | 13.40 (12.10, 14.60) | 13.40 (12.10, 14.53) | 13.65 (12.30, 15.30) | 0.425 |
| D-dimer/(mg·L-1) | 0.25 (0.11, 0.58) | 0.23 (0.10, 0.44) | 0.32 (0.16, 1.35) | 0.033 |